BMRN vs CTRN · P/E 40, rev $2.85B vs rev $753.1M
Biomarin Pharmaceutical Inc (BMRN) versus Citi Trends Inc (CTRN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Citi Trends Inc (CTRN) is a apparel retail company listed on US.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported CTRN revenue for 2025-02-01 was $753.1M. Net income was -$43.2M. Revenue was up 0.7% from 2024-02-03 to 2025-02-01. CTRN currently screens at market cap $258.4M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CTRN currently screens at market cap $258.4M.
Not investment advice. Open the BMRN and CTRN stock pages for the full models.
Not investment advice.